Your browser doesn't support javascript.
loading
Metronomic Cyclophosphamide With Cisplatin and Bevacizumab for Refractory Anaplastic Ependymoma: A Retrospective Study.
DE Laclos, Xavier Choderlos; Frappaz, Didier; Ahle, Guido; Bronnimann, Charlotte; Catry-Thomas, Isabelle; Joncour, Anthony; Ghiringhelli, Francois; Vauleon, Elodie.
Affiliation
  • DE Laclos XC; Oncology Department, Eugène Marquis Centre, Rennes, France.
  • Frappaz D; Neuro-oncology Department, Léon-Bérard Centre, Lyon, France.
  • Ahle G; Neurology Department, Civil Hospitals of Colmar, Colmar, France.
  • Bronnimann C; Saint André Hospital, University Hospital, Bordeaux, France.
  • Catry-Thomas I; Saint André Hospital, University Hospital, Bordeaux, France.
  • Joncour A; Oncology Department, University Hospital, Poitiers, France.
  • Ghiringhelli F; Oncology Department, Georges-François Leclerc Centre, Dijon, France.
  • Vauleon E; Oncology Department, Eugène Marquis Centre, Rennes, France; e.vauleon@rennes.unicancer.fr.
Anticancer Res ; 42(8): 3863-3867, 2022 Aug.
Article in En | MEDLINE | ID: mdl-35896241
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Ependymoma Type of study: Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Humans Language: En Journal: Anticancer Res Year: 2022 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Ependymoma Type of study: Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Humans Language: En Journal: Anticancer Res Year: 2022 Document type: Article